Cited by 123Nicotinic Acetylcholine Receptors StudySmoking Behavior and CessationNeurotransmitter Receptor Influence on Behavior

Nicotine consumption is regulated by a human polymorphism in dopamine neurons

Open access
Morel, C, Fattore, L, Pons, S, Hay, Y A, Marti, F, Lambolez, B, De Biasi, M, Lathrop, M +3 more·2014·Molecular Psychiatry

Abstract

Smoking is the most important preventable cause of morbidity and mortality worldwide. Recent genome-wide association studies highlighted a human haplotype on chromosome 15 underlying the risk for tobacco dependence and lung cancer. Several polymorphisms in the CHRNA3-CHRNA5-CHRNB4 cluster coding for the nicotinic acetylcholine receptor (nAChR) α3, α5 and β4 subunits were implicated. In mouse models, we define a key role in the control of sensitivity to nicotine for the α5 subunit in dopaminergic (DAergic) neurons of the ventral tegmental area (VTA). We first investigated the reinforcing effects of nicotine in drug-naive α5(-/-) mice using an acute intravenous nicotine self-administration task and ex vivo and in vivo electrophysiological recordings of nicotine-elicited DA cell activation. We designed lentiviral re-expression vectors to achieve targeted re-expression of wild-type or mutant α5 in the VTA, in general, or in DA neurons exclusively. Our results establish a crucial role for α5*-nAChRs in DAergic neurons. These receptors are key regulators that determine the minimum nicotine dose necessary for DA cell activation and thus nicotine reinforcement. Finally, we demonstrate that a single-nucleotide polymorphism, the non-synonymous α5 variant rs16969968, frequent in many human populations, exhibits a partial loss of function of the protein in vivo. This leads to increased nicotine consumption in the self-administration paradigm. We thus define a critical link between a human predisposition marker, its expression in DA neurons and nicotine intake.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2013.158

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The impact of the mutation defining the risk allele has been validated repeatedly in vitro and in animal models.

    “The impact of the mutation that defines the risk allele has been validated repeatedly in vitro and in animal models (Kuryatov et al. 2011; Morel et al. 2014).”

    From Nicotine Withdrawal (2015) · cites this paper as Morel et al. 2014

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. [3]Salas R, Pieri F, De Biasi M. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci 2004; 24: 10035– 10039. 15537871 PMC6730195
  2. [4]Wang JC, Cruchaga C, Saccone NL, Bertelsen S, Liu P, Budde JP Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 2009; 18: 3125– 3135. 19443489 PMC2714722
  3. [5]Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 2008; 165: 1163– 1171. 18519524 PMC2574742
  4. [6]Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 2009; 78: 703– 711. 19481063
  5. [7]Klink R, de Kerchove d’Exaerde A, Zoli M, Changeux JP. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 2001; 21: 1452– 1463. 11222635 PMC6762941
  6. [8]Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011; 471: 597– 601. 21278726 PMC3079537
  7. [9]Chatterjee S, Santos N, Holgate J, Haass-Koffler CL, Hopf FW, Kharazia V The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area. PLoS ONE 2013; 8: e68300. 23869214 PMC3712017
  8. [10]Tuesta LM, Fowler CD, Kenny PJ. Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol 2011; 82: 984– 995. 21740894 PMC3163076
  9. [12]Di Ciano P, Everitt BJ. Contribution of the ventral tegmental area to cocaine-seeking maintained by a drug-paired conditioned stimulus in rats. Eur J Neurosci 2004; 19: 1661– 1667. 15066162
  10. [13]Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255– 257. 8717040
  11. [14]Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement. Mol Psychiatry 2012; 18: 382– 393. 22751493
  12. [15]Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M. The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 2003; 63: 1059– 1066. 12695534
  13. [16]Martellotta MC, Kuzmin A, Zvartau E, Cossu G, Gessa GL, Fratta W. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 1995; 52: 271– 274. 8577790
  14. [17]Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 2008; 28: 12318– 12327. 19020025 PMC2819191
  15. [18]Marti F, Arib O, Morel C, Dufresne V, Maskos U, Corringer P-J Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.. Neuropsychopharmacology 2011; 36: 2244– 2257. 21716264 PMC3176561
  16. [22]Tolu S, Avale ME, Nakatani H, Pons S, Parnaudeau S, Tronche F A versatile system for the neuronal subtype specific expression of lentiviral vectors. FASEB J 2010; 24: 723– 730. 19858094
  17. [23]Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984; 4: 2877– 2890. 6150071 PMC6564720
  18. [24]Grace AA, Bunney BS.. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 1984; 4: 2866– 2876. 6150070 PMC6564731
  19. [26]Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 2009; 89: 73– 120. 19126755 PMC2713585
  20. [28]Jackson KJ, Martin BR, Changeux JP, Damaj MI. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 2008; 325: 302– 312. 18184829 PMC3821841
  21. [29]Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA The role of alpha5 nicotinic acetylcholine receptors in the pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther 2010; 334: 137– 146. 20400469 PMC2912049
  22. [30]Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux J-P Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 2006; 50: 911– 921. 16772172
  23. [31]Tsuneki H, Klink R, Léna C, Korn H, Changeux JP. Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta. Eur J Neurosci 2000; 12: 2475– 2485. 10947823
  24. [32]Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A, Role L. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature 1996; 380: 347– 351. 8598930
  25. [33]Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Pich EM Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998; 391: 173– 177. 9428762
  26. [34]Fowler CD, Tuesta L, Kenny PJ. Role of α5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice. Psychopharmacology 2013; 229: 503– 513. PMC3930613 23958943
  27. [35]Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S Aversion to Nicotine Is Regulated by the Balanced Activity of beta4 and alpha5 Nicotinic Receptor Subunits in the Medial Habenula. Neuron 2011; 70: 522– 535. 21555077
  28. [36]Scholze P, Koth G, Orr-Urtreger A, Huck S. Subunit composition of α5-containing nicotinic receptors in the rodent habenula. J Neurochem 2012; 121: 551– 560. 22380605 PMC3350326
  29. [37]Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ. Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J Neurosci 2012; 32: 2352– 2356. 22396410 PMC3742968
  30. [38]Kravitz AV, Tye LD, Kreitzer AC. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 2012; 15: 816– 818. 22544310 PMC3410042
  31. [39]Kitai S, Shepard P, Callaway J, Scroggs R. Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol 1999; 9: 1– 8. 10607649
  32. [40]Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 2000; 27: 349– 357. 10985354

Cited by

Sorted by citations

Authors
Morel, C., Fattore, L., Pons, S., Hay, Y. A., Marti, F., Lambolez, B., De Biasi, M., Lathrop, M., Fratta, W., Maskos, U., & Faure, P.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • National Research Council (IT)
  • Fondation Jean Dausset-CEPH (FR)
  • University of Cagliari (IT)
Corresponding author
Maskos, U
Venue
Molecular Psychiatry
Published
2013-12-03
Volume
19
Issue
8
Pages
930-936
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2010762896
Cited by
123
References
8
Citations by year
2026: 1 · 2025: 10 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 6 · 2020: 8 · 2019: 11 · 2018: 17 · 2017: 11 · 2016: 13 · 2015: 17 · 2014: 8
FWCI
5.68
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
Funders
  • National Institute on Drug Abuse (R21DA029157, DA029157)
  • National Cancer Institute (U19CA148127)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
nicotine self-administration, nicotinic acetylcholine receptors, CHRNA5, dopaminergic neurons, ventral tegmental area, nicotine reinforcement, rs16969968, single nucleotide polymorphisms, loss-of-function mutations, tobacco dependence, nicotine sensitivity
MeSH terms
Action Potentials, Animals, Male, Nicotine, Receptors, Nicotinic, Reinforcement, Psychology, Self Administration, Ventral Tegmental Area, Mice, Knockout, Polymorphism, Single Nucleotide, Mice, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review